FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to medical diagnostics, and can be used for prediction of risk of complicated gastric ulcer. Gastric biopsy is carried out with sampling of two biopsy materials: in the body region and in the antrum along the greater curvature, one biopsy material along the lesser curvature in the body region. Expression level of microRNA-146a is determined, and the arithmetic mean is calculated based on the results of three repetitions. If value is 2.904±0.153, a high risk of developing complicated gastric ulcer is predicted.
EFFECT: method provides more accurate prediction of a high risk of developing complicated gastric ulcer by determining the expression level of microRNA-146a in gastric biopsy materials.
1 cl, 3 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING RISK OF DEVELOPING COMPLICATED GASTRIC ULCER BASED ON DETERMINING EXPRESSION LEVEL OF MICRORNA-155 | 2024 |
|
RU2823477C1 |
METHOD OF IMMUNODIAGNOSIS OF GASTRODUODENAL ZONE DISEASES | 2017 |
|
RU2677228C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF GASTROESOPHAGEAL REFLUX DISEASE | 2012 |
|
RU2530634C2 |
METHOD FOR PREVENTING TUBERCULOSIS IN INFLAMMATORY INTESTINAL DISEASES | 2018 |
|
RU2712943C1 |
METHOD FOR DETERMINING RISK OF ISCHEMIC HEART DISEASE | 2013 |
|
RU2532361C1 |
BACTERIOLOGICAL DIAGNOSTIC TECHNIQUE FOR Helicobacter pylori IN GASTRIC MUCOSA OF PATIENTS SUFFERING GASTRODUODENAL PATHOLOGY | 2011 |
|
RU2478957C2 |
METHOD FOR TREATING GASTRODUODENAL PEPTIC ULCERS | 1995 |
|
RU2097048C1 |
METHOD FOR PREDICTING CLINIC COURSE OF PEPTIC GASTRODUODENAL ULCER AND ITS COMPLICATIONS | 2005 |
|
RU2284037C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR HEPATIC STEATOSIS AND STEATOHEPATITIS | 2013 |
|
RU2545990C2 |
METHOD FOR EVALUATING RISK OF DUODENAL ULCER IN KHAKASS BY GENETIC ANALYSIS | 2014 |
|
RU2563828C1 |
Authors
Dates
2024-07-23—Published
2024-01-25—Filed